Takafumi Mizushige Selected Research

Takafumi Mizushige Research Topics

4	Hypertrophy 01/2022 - 12/2010
3	Atrophy 01/2021 - 02/2008
2	Obesity 03/2022 - 01/2017
2	Insulin Resistance 09/2018 - 08/2015
2	Body Weight (Weight, Body) 01/2015 - 02/2008
1	Muscular Atrophy (Muscle Atrophy) 01/2021
1	Cognitive Dysfunction 12/2019
1	Weight Gain 01/2019
1	Anorexia 01/2015
1	Olfactory Nerve Injuries 01/2009
1	Fibrosis (Cirrhosis) 02/2007

4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2015
3	IsoflavonesIBA 03/2022 - 02/2007
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2010
3	LipidsIBA 01/2021 - 12/2010
3	Peptides (Polypeptides)IBA 12/2019 - 01/2017
2	Fish ProteinsIBA 01/2017 - 01/2015
2	daidzeinIBA 01/2015 - 02/2007
1	Dietary Fats (Dietary Fat)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021
1	Lipase (Acid Lipase)FDA Link 01/2021
1	Caseins (Casein)FDA Link 01/2019
1	Blood Glucose (Blood Sugar)IBA 09/2018
1	DipeptidesIBA 09/2018
1	ThermolysinIBA 09/2018
1	Whey ProteinsIBA 09/2018
1	Lactoglobulins (beta-Lactoglobulin)FDA Link 09/2018
1	Insulin (Novolin)FDA Link 09/2018
1	Agouti-Related ProteinIBA 01/2017
1	Neuropeptide YIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	alanylglutamineIBA 08/2015
1	N-glycylglutamic acidIBA 08/2015
1	phospholipid emulsion soybean oil (Intralipid)IBA 01/2015
1	GalaninIBA 01/2015
1	EmulsionsIBA 01/2015
1	Naltrexone (ReVia)FDA LinkGeneric 01/2015
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2015
1	HydrocarbonsIBA 01/2009
1	Mineral Oil (Liquid Paraffin)FDA LinkGeneric 01/2009
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2008
1	GenisteinIBA 02/2007